Show simple item record

dc.contributor.authorMa, Shan
dc.contributor.authorVenkatesh, Aditya
dc.contributor.authorLangellotto, Fernanda
dc.contributor.authorLe, Yun Z.
dc.contributor.authorHall, Michael N.
dc.contributor.authorRuegg, Markus A.
dc.contributor.authorPunzo, Claudio
dc.date2022-08-11T08:09:44.000
dc.date.accessioned2022-08-23T16:41:34Z
dc.date.available2022-08-23T16:41:34Z
dc.date.issued2015-06-01
dc.date.submitted2016-04-05
dc.identifier.citationExp Eye Res. 2015 Jun;135:1-13. doi: 10.1016/j.exer.2015.04.006. Epub 2015 Apr 14. <a href="http://dx.doi.org/10.1016/j.exer.2015.04.006">Link to article on publisher's site</a>
dc.identifier.issn0014-4835 (Linking)
dc.identifier.doi10.1016/j.exer.2015.04.006
dc.identifier.pmid25887293
dc.identifier.urihttp://hdl.handle.net/20.500.14038/39910
dc.description.abstractCones are the primary photoreceptor (PR) cells responsible for vision in humans. They are metabolically highly active requiring phosphoinositide 3-kinase (PI3K) activity for long-term survival. One of the downstream targets of PI3K is the kinase mammalian target of rapamycin (mTOR), which is a key regulator of cell metabolism and growth, integrating nutrient availability and growth factor signals. Both PI3K and mTOR are part of the insulin/mTOR signaling pathway, however if mTOR is required for long-term PR survival remains unknown. This is of particular interest since deregulation of this pathway in diabetes results in reduced PR function before the onset of any clinical signs of diabetic retinopathy. mTOR is found in two distinct complexes (mTORC1 and mTORC2) that are characterized by their unique accessory proteins RAPTOR and RICTOR respectively. mTORC1 regulates mainly cell metabolism in response to nutrient availability and growth factor signals, while mTORC2 regulates pro-survival mechanisms in response to growth factors. Here we analyze the effect on cones of loss of mTORC1, mTORC2 and simultaneous loss of mTORC1 and mTORC2. Interestingly, neither loss of mTORC1 nor mTORC2 affects cone function or survival at one year of age. However, outer and inner segment morphology is affected upon loss of either complex. In contrast, concurrent loss of mTORC1 and mTORC2 leads to a reduction in cone function without affecting cone viability. The data indicates that PI3K mediated pro-survival signals diverge upstream of both mTOR complexes in cones, suggesting that they are independent of mTOR activity. Furthermore, the data may help explain why PR function is reduced in diabetes, which can lead to deregulation of both mTOR complexes simultaneously. Finally, although mTOR is a key regulator of cell metabolism, and PRs are metabolically highly active, the data suggests that the role of mTOR in regulating the metabolic transcriptome in healthy cones is minimal.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=25887293&dopt=Abstract">Link to Article in PubMed</a>
dc.rights<p>© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAnimals
dc.subjectCell Survival
dc.subjectDiabetic Retinopathy
dc.subjectDisease Models, Animal
dc.subjectElectroretinography
dc.subjectEye Proteins
dc.subjectImmunosuppressive Agents
dc.subjectMice
dc.subjectMice, Inbred C57BL
dc.subjectMultiprotein Complexes
dc.subjectPhosphatidylinositol 3-Kinases
dc.subjectRetinal Cone Photoreceptor Cells
dc.subjectSignal Transduction
dc.subjectSirolimus
dc.subjectTOR Serine-Threonine Kinases
dc.subjectCone survival
dc.subjectDiabetic retinopathy
dc.subjectNeuroprotective
dc.subjectPI3K
dc.subjectPhotoreceptors
dc.subjectRetinitis pigmentosa
dc.subjectVisual function
dc.subjectmTOR
dc.subjectCellular and Molecular Physiology
dc.subjectEye Diseases
dc.subjectOphthalmology
dc.titleLoss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival
dc.typeJournal Article
dc.source.journaltitleExperimental eye research
dc.source.volume135
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3716&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/2712
dc.identifier.contextkey8426771
refterms.dateFOA2022-08-23T16:41:34Z
html.description.abstract<p>Cones are the primary photoreceptor (PR) cells responsible for vision in humans. They are metabolically highly active requiring phosphoinositide 3-kinase (PI3K) activity for long-term survival. One of the downstream targets of PI3K is the kinase mammalian target of rapamycin (mTOR), which is a key regulator of cell metabolism and growth, integrating nutrient availability and growth factor signals. Both PI3K and mTOR are part of the insulin/mTOR signaling pathway, however if mTOR is required for long-term PR survival remains unknown. This is of particular interest since deregulation of this pathway in diabetes results in reduced PR function before the onset of any clinical signs of diabetic retinopathy. mTOR is found in two distinct complexes (mTORC1 and mTORC2) that are characterized by their unique accessory proteins RAPTOR and RICTOR respectively. mTORC1 regulates mainly cell metabolism in response to nutrient availability and growth factor signals, while mTORC2 regulates pro-survival mechanisms in response to growth factors. Here we analyze the effect on cones of loss of mTORC1, mTORC2 and simultaneous loss of mTORC1 and mTORC2. Interestingly, neither loss of mTORC1 nor mTORC2 affects cone function or survival at one year of age. However, outer and inner segment morphology is affected upon loss of either complex. In contrast, concurrent loss of mTORC1 and mTORC2 leads to a reduction in cone function without affecting cone viability. The data indicates that PI3K mediated pro-survival signals diverge upstream of both mTOR complexes in cones, suggesting that they are independent of mTOR activity. Furthermore, the data may help explain why PR function is reduced in diabetes, which can lead to deregulation of both mTOR complexes simultaneously. Finally, although mTOR is a key regulator of cell metabolism, and PRs are metabolically highly active, the data suggests that the role of mTOR in regulating the metabolic transcriptome in healthy cones is minimal.</p>
dc.identifier.submissionpathoapubs/2712
dc.contributor.departmentDepartment of Ophthalmology
dc.source.pages1-13


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1_s2.0_S0014483515001189_main.pdf
Size:
4.089Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

<p>© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
Except where otherwise noted, this item's license is described as <p>© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>